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Case report
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Anaphylaxis as a causative
factor in loss of consciousness
in an elderly woman.
Mastocytosis — a case report
Abstract
A female patient, 72-years-old with recurrent systemic hypotension, was admitted to the Allergology Depart-
ment. She had long been diagnosed with urticaria pigmentosa. She also had a history of planoepithelial
vaginal cancer, mitral valvular insufficiency and osteoporosis. Recurrent episodes of anaphylaxis and  masto-
cytosis were diagnosed at the Department of Allergology.
It is important to consider a systemic hypersensitivity reaction in differential diagnosis even in elderly
patients, since it may mimic other medical emergencies. The unusual and broad spectrum of symptoms in
mastocytosis usually requires the cooperation of different specialists.
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Introduction
In the case of an elderly patient with loss of
consciousness, the main differential diagnosis is syn-
cope due to heart disease, neurological disorders
and miscellaneous conditions [1, 2].
Anaphylaxis is a severe, potentially life-threaten-
ing, systemic hypersensitivity reaction [3] that can
mimic other medical emergencies, and thus should
be considered in a differential diagnosis even in
elderly patients [4].
Systemic hypotension leading to the point of
unconsciousness is one of the most severe symp-
toms of anaphylaxis. However, in elderly patients
this will not usually be considered causative when
an anaphylactic reaction occurs for the first time.
In this paper, a case of recurrent systemic hy-
potension due to anaphylaxis in the course of mas-
tocytosis is reported.
Case report
A female patient (JO), 72-years-old, was admit-
ted as an outpatient to the Department of Allergol-
ogy at the Medical University of Gdansk, Poland, in
November 2008 because of recurrent syncopes due
to hypotension and suspected of having mastocy-
tosis. She had been diagnosed with urticaria pig-
mentosa a long time previously (Figure 1). The first
skin lesions occurred when she was thirty years old.
She also had a history of planoepithelial vaginal
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cancer (she underwent surgery and radiotherapy in
2000) and deep vein thrombosis a few years earlier.
At the time of admission she complained of a
recurrent sudden weakness due to hypotension and
four episodes of a loss of consciousness during the
previous two years. The patient related these epi-
sodes to the intake of food (nuts, chocolate and
strawberries) and drugs (antibiotics and heparin).
In 1991, while visiting Italy, she developed anaphy-
lactic shock-like symptoms after aspirin intake, al-
though no medical documentation was available.
In September 2007 she was admitted to the In-
ternal Diseases and Rheumatology Department in
Warsaw, Poland, because of weakness and fever. At
this time, an abdomen CT revealed hepato- and
splenomegaly and a USG detected neck and axillary
lymphadenopathy. She was seen by a haematolo-
gist but no final diagnosis was made; additional
findings, however, included mitral valvular insuffi-
ciency (although not significant haemodynamical-
ly) and osteoporosis.
Finally, she was sent to the Allergology Depart-
ment in Gdansk at her own request.
Consultation at the Allergology Department con-
firmed systemic mastocytosis. No subjective symp-
toms were present at the time of the consultation:
cutaneous lesions presented as disseminated yel-
low-brown patches on the skin over her entire body;
there were positive signs of Darier's disease; and
the serum triptase level was highly elevated (> 200
µg/ml). Further examination included the following:
bone marrow and skin biopsy, serum total and spe-
cific IgE concentration (it was not possible to per-
form a skin prick test because of generalized urti-
caria pigmentosa), abdominal imaging study, and
the expression of mast cells CD25 and CD2. The
patient was told to avoid triggering factors causing
the release of mast cell mediators, such as aspirin,
alcohol, some food (chocolate and nuts), rapid
changes in temperature, rubbing, and exercise. She
received an emergency kit — containing adrenaline
for self-application, rapidly acting H1 antihistamin-
ics and oral corticosteroids — and she was recom-
mended to take non-sedating H1 antihistaminics as
continuous prophylactic medication.
Discussion
Mastocytosis is a rare and difficult-to-diagnose
group of disorders characterized by a pathological
increase in mast cells  in tissue, including skin, bone
marrow, liver, spleen and lymph nodes. In mastocy-
tosis, symptoms and signs of disease are typically
related to the tissue mast cell burden and to the
response for the release of mast cell mediators [5].
This unusual and broad spectrum of symptoms,
therefore, requires the cooperation of different spe-
cialists [6]. A curative treatment for mastocytosis
does not exist and therapy should be carefully con-
sidered for each patient. The management of pa-
tients within all categories of mastocytosis includes
their avoidance of factors triggering acute media-
tor release, treatment of acute mast cell release (i.e.
systemic hypotension), treatment of chronic media-
tor release, and an attempt to treat organ infiltra-
tion by mast cells [5].
Syncope is a common clinical problem. The esti-
mated incidence of self-reported syncope is 6.2 per
1,000 person-years in the Framingam study [7]. The
frequency of a fall in blood pressure on standing
increases with age [8]. The prevalence of syncope in
subjects aged 70 years and older is near 30% [9].
Syncope is a clinical manifestation of the interrup-
tion of global cerebral perfusion. In the elderly, es-
pecially in patients with a history of heart disease, a
cardiac cause of loss of consciousness is the most
likely. The most common neurogenic causes of a
transient loss of consciousness are cerebrovascular
disease [transient ischemic attack (TIA), or athero-
thrombotic or cardioembolic stroke] and epilepsy.
Patients with TIA are at increased risk of stroke,
cardiovascular events, and death. Transient ischem-
ic attack and stroke must be recognized and treat-
ed urgently [10]. Neurogenic syncope could be as-
sociated with vertebrobasilar insufficiency and oth-
er abnormalities of the vertebral arteries i.e. arterio-
sclerotical plaques [11].
In anaphylactic episodes, the release of mast cell-
derived mediators leads to vasodilatation, systemic
hypotension and hypoperfusion of the central ner-
vous system. In the case being described, the cause
Figure 4. Urticaria pigmentosa
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of systemic hypotension was anaphylaxis. The re-
ported incidence of anaphylaxis ranges from 3.2 to
20 per 100,000 head of population [12]. Determin-
ing the exact diagnosis is an important challenge,
since the proper final diagnosis and treatment are
guarantors of a successful outcome [2].
Mastocytosis is a rare disease, the prevalence
being less than 0.01% in the whole population [6].
Anaphylaxis is a frequent event in mastocytosis
due to strongly increased mediator release from
the increased number of mast cell. This explains
the much higher prevalence of anaphylaxis in mas-
tocytosis than in the general population and its
severe and sometimes fatal course [13]. Mastocy-
tosis should be suspected in patients with recur-
rent anaphylaxis who present with syncopal or near-
syncopal episodes without associated hives or an-
gioedema [14]. Patients with mastocytosis accom-
panied by extensive skin disease have an increased
risk of anaphylaxis [15]. A delay in establishing a
diagnosis of mastocytosis can result in either late or
inappropriate treatment and subsequent morbidity
and mortality.
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